Example: Heart Attack

Clinical Trials Sponsored by Exsulin Corporation

Total 3 results

NCT00995540

Terminated

Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

Conditions: Type 1 Diabetes Mellitus
NCT00071422

Completed

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

Conditions: Diabetes Mellitus, Non-Insulin-Dependent
NCT00071409

Completed

Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes

Conditions: Diabetes Mellitus, Insulin-Dependent